Search

Displaying results 7671 - 7680 of 10000 in total
  1. Drug

    Combretastatin

    go.drugbank.com/drugs/DB12596
    Investigational

    Combretastatin has been investigated for the treatment of Anaplastic Thyroid Cancer.

  2. Drug

    Intetumumab

    go.drugbank.com/drugs/DB12701
    Investigational

    Intetumumab has been used in trials studying the treatment of Melanoma.

  3. Drug

    N-Ethylretinamide

    go.drugbank.com/drugs/DB03917
    Experimental

    N-Ethylretinamide is the ethylamide of all-trans B-retinoic acid.

  4. Drug

    MVA-BN-brachyury-TRICOM vaccine

    go.drugbank.com/drugs/DB17424
    Investigational

    of T-cell co-stimulatory molecules (TRICOM), which is comprised of the three human immune-enhancing co-stimulatory molecules B7-1, ICAM-1 and LFA-3. … [L44513] MVA-BN-brachyury-TRICOM vaccine is administered as a priming vaccine, followed by the administration of the fowlpox virus(FPV)‐Brachyury booster vaccine.

  5. Drug

    Inactivated SARS-Cov-2 Vaccine

    go.drugbank.com/drugs/DB15862
    Investigational

    Developed by Sinopharm's Wuhan Institute of Biological Products co., this vaccine consists of the WIV04 strain of SARS-CoV-2. … [A220158] Results from these trials showed low rates of adverse reactions and demonstrated immunogenicity.

  6. Drug

    Epofolate

    go.drugbank.com/drugs/DB12266
    Investigational

    Epofolate has been used in trials studying the treatment of Advanced Solid Tumors. … Antitumor activity was not demonstrated and further development of BMS-753493 has been discontinued.

  7. Drug

    PZM21

    go.drugbank.com/drugs/DB14030
    Experimental

    PZM21 is a novel μ-opioid receptor (MOPr) ligand that has been reported to induce minimal arrestin recruitment and be devoid of the respiratory depressant effects characteristic of classical μ-opioid ligands

  8. Drug

    Itepekimab

    go.drugbank.com/drugs/DB16206
    Investigational

    Itepekimab is under investigation in clinical trial NCT03546907 (Proof-of-concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-il-33 Mab) in Patients With Moderate-to-severe

  9. Drug

    HPV-16 trojan peptide vaccine

    go.drugbank.com/drugs/DB17496
    Investigational

    HPV-16 trojan peptide vaccine is an investigational cancer immunotherapy consisting of a novel Trojan peptide complex, composed of human papilloma virus 16 (HPV 16) epitopes, to stimulate antigen-specific

  10. Drug

    Ivarimod

    go.drugbank.com/drugs/DB19605
    Experimental

    The usage of the INN stem '-imod' in the name indicates that Ivarimod is a immunomodulator, both stimulant/suppressive and stimulant. Ivarimod has a monoisotopic molecular weight of 512.33 Da.